|
"jin yuan shih"的相關文件
顯示項目 231-280 / 468 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019-03-04T07:47:57Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Chen, Kuan-Yu;Tsai, Tzu Hsiu;CHONG-JEN YU;JIN-YUAN SHIH;CHAO-CHI HO;WEI-YU LIAO; WEI-YU LIAO; CHAO-CHI HO; Tsai, Tzu Hsiu; Chen, Kuan-Yu; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T07:37:48Z |
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
|
Garon, Edward;Levy, Benjamin;Varea, Rocio;Cheng, Rebecca;Sashegyi, Andreas;Winfree, Katherine B.;Lee, Pablo;Tsao, Anne;Socinski, Mark A.;Shepherd, Frances A.;Imbimbo, Martina;Garassino, Marina Chiara;Reck, Martin;JIN-YUAN SHIH; Reck, Martin; Garassino, Marina Chiara; Imbimbo, Martina; Shepherd, Frances A.; Socinski, Mark A.; JIN-YUAN SHIH; Tsao, Anne; Lee, Pablo; Winfree, Katherine B.; Sashegyi, Andreas; Cheng, Rebecca; Varea, Rocio; Levy, Benjamin; Garon, Edward |
| 臺大學術典藏 |
2019-03-04T07:33:42Z |
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
|
Chang, Gee Chen;Cseh, Agnieszka;Carrière, Philippe;Lorence, Robert M.;Chih-Hsin Yang, James;Unk, Mojca;Spataro, Vito;Gautschi, Oliver;Nechushtan, Hovav;Curioni-Fontecedro, Alessandra;Peters, Solange;WEI-YU LIAO;JIN-YUAN SHIH; Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; JIN-YUAN SHIH; WEI-YU LIAO; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M.; Carri?re, Philippe; Cseh, Agnieszka; Chang, Gee Chen |
| 臺大學術典藏 |
2019-03-04T06:56:32Z |
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
|
Lin, Yi Ting;Liu, Chi;Yeh, Yu Hsuan;Chiu, An Chieh;Tseng, Ruo Yu;Lin, Yun Chieh;Lin, Yu Chin;Chen, Li Yu;Weng, Chien Hui;CHING-CHOW CHEN;JIM-MIN FANG;JIN-YUAN SHIH; Weng, Chien Hui; Chen, Li Yu; Lin, Yu Chin; JIN-YUAN SHIH; Lin, Yun Chieh; Tseng, Ruo Yu; Chiu, An Chieh; Yeh, Yu Hsuan; Liu, Chi; Lin, Yi Ting; JIM-MIN FANG; CHING-CHOW CHEN |
| 臺大學術典藏 |
2019-03-04T06:51:46Z |
Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma
|
Yang, Ching-Yao;CHONG-JEN YU;JIN-YUAN SHIH;WEI-YU LIAO;MIN-SHU HSIEH; Yang, Ching-Yao; MIN-SHU HSIEH; WEI-YU LIAO; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T06:50:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang, James Chih Hsin;Lin, Zhong Zhe;Lee, Jih Hsiang;Yang, Ching Yao;Lin, Yen Ting;Chen, Kuan-Yu;CHONG-JEN YU;JIN-YUAN SHIH;CHIA-LIN HSU;CHAO-CHI HO;WEI-YU LIAO;JIN-SHING CHEN; Lin, Yen Ting; JIN-SHING CHEN; WEI-YU LIAO; CHAO-CHI HO; CHIA-LIN HSU; Yang, Ching Yao; Chen, Kuan-Yu; Lee, Jih Hsiang; Lin, Zhong Zhe; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T06:48:10Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Liu, Yi-Nan;Chang, Tzu-Hua;Wu, Shang-Gin;Hsu, Chia Lang;Tsai, Meng Feng;JIN-YUAN SHIH;CHONG-JEN YU;YIH-LEONG CHANG; Wu, Shang-Gin; Chang, Tzu-Hua; Tsai, Meng Feng; Liu, Yi-Nan; Hsu, Chia Lang; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T06:43:20Z |
MicroRNA in Lung Cancer Metastasis
|
Liu, Yi-Nan;Chang, Tzu-Hua;Wu, Shang-Gin;JIN-YUAN SHIH; Wu, Shang-Gin; Chang, Tzu-Hua; Liu, Yi-Nan; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-02-27T07:04:21Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
James Chih-Hsin Yang;Yen-Ting Lin;JIN-YUAN SHIH;CHONG-JEN YU; Yen-Ting Lin; Chong-Jen Yu; James Chih-Hsin Yang; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019 |
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Nakagawa K.;Garon E.B.;Seto T.;Nishio M.;Ponce Aix S.;Paz-Ares L.;Chiu C.-H.;Park K.;Novello S.;Nadal E.;Imamura F.;Yoh K.;Jin-Yuan Shih;Au K.H.;Moro-Sibilot D.;Enatsu S.;Zimmermann A.;Frimodt-Moller B.;Visseren-Grul C.;Reck M.;Chu Q.;Cortot A.;Pujol J.-L.;Fabre E.;Lamour C.;Bischoff H.;Kollmeier J.;Kimmich M.;Engel-Riedel W.;Hammerschmidt S.;Sch?Tte W.;Syrigos K.;Ho J.C.M.;Au K.-H.;Ardizzoni A.;Pasello G.;Gregorc V.;Del Conte A.;Galetta D.;Takahashi T.;Kumagai T.;Hotta K.;Goto Y.;Hosomi Y.;Sakai H.;Takiguchi Y.;Kim Y.H.;Kurata T.;Yamaguchi H.;Daga H.;Okamoto I.;Satouchi M.;Ikeda S.;Kasahara K.;Atagi S.;Azuma K.;Aoe K.;Horio Y.;Yamamoto N.;Tanaka H.;Watanabe S.;Nogami N.;Ozaki T.;Koyama R.;Hirashima T.;Kaneda H.;Tomii K.;Fujita Y.;Seike M.;Nishimura N.;Kato T.;Ichiki M.;Saka H.;Hirano K.;Nakahara Y.;Sugawara S.;Kim S.-W.;Min Y.J.;Lee H.W.;Kang J.-H.;An H.J.;Lee K.H.;Kim J.-S.;Lee G.-W.;Lee S.Y.;Alexandru A.;Udrea A.A.;Juan-Vidal ?.;Nadal-Alforja E.;Gil-Bazo I.;Ponce-Aix S.;Rubio-Viqueira B.;Alonso Garcia M.;Felip Font E.;Fuentes Pradera J.;Coves Sarto J.;Lin M.-C.;Su W.-C.;Hsia T.-C.;Chang G.-C.;Wei Y.-F.;Su J.;Cicin I.;Goksel T.;Harputluoglu H.;Ozyilkan O.;Henning I.;Popat S.;Hatcher O.;Mileham K.;Acoba J.;Garon E.;Jung G.;Raj M.;Martin W.;Dakhil S.; Hirano K.; Nakahara Y.; Saka H.; Ichiki M.; Kato T.; Nishimura N.; Seike M.; Fujita Y.; Tomii K.; Kaneda H.; Hirashima T.; Koyama R.; Aoe K.; Horio Y.; Yamamoto N.; Tanaka H.; Watanabe S.; Nogami N.; Ozaki T.; Azuma K.; Atagi S.; Sch?tte W.; Syrigos K.; Ho J.C.M.; Au K.-H.; Ardizzoni A.; Pasello G.; Gregorc V.; Del Conte A.; Galetta D.; Takahashi T.; Kumagai T.; Hotta K.; Goto Y.; Hosomi Y.; Sakai H.; Takiguchi Y.; Kim Y.H.; Kurata T.; Yamaguchi H.; Daga H.; Okamoto I.; Satouchi M.; Ikeda S.; Kasahara K.; Nakagawa K.; Garon E.B.; Seto T.; Nishio M.; Ponce Aix S.; Paz-Ares L.; Chiu C.-H.; Park K.; Novello S.; Nadal E.; Imamura F.; Yoh K.; JIN-YUAN SHIH; Au K.H.; Moro-Sibilot D.; Enatsu S.; Zimmermann A.; Frimodt-Moller B.; Visseren-Grul C.; Reck M.; Chu Q.; Cortot A.; Pujol J.-L.; Fabre E.; Lamour C.; Bischoff H.; Kollmeier J.; Kimmich M.; Engel-Riedel W.; Hammerschmidt S.; Wei Y.-F.; Chang G.-C.; Hsia T.-C.; Su W.-C.; Lin M.-C.; Coves Sarto J.; Fuentes Pradera J.; Felip Font E.; Alonso Garcia M.; Rubio-Viqueira B.; Ponce-Aix S.; Gil-Bazo I.; Nadal-Alforja E.; Juan-Vidal ?.; Sugawara S.; Kim S.-W.; Min Y.J.; Lee H.W.; Kang J.-H.; An H.J.; Lee K.H.; Kim J.-S.; Lee G.-W.; Lee S.Y.; Alexandru A.; Udrea A.A.; Su J.; Cicin I.; Goksel T.; Harputluoglu H.; Ozyilkan O.; Henning I.; Popat S.; Hatcher O.; Mileham K.; Acoba J.; Garon E.; Jung G.; Raj M.; Martin W.; Dakhil S. |
| 臺大學術典藏 |
2019 |
Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
|
Yu C.-J.; JIN-YUAN SHIH; Chen K.-Y.; Chang L.-Y.; Lim C.-K.; Chang L.-C. |
| 臺大學術典藏 |
2019 |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; JIN-YUAN SHIH; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Jin-Yuan Shih;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Lin C.-C.; Chen J.-S.; Lin Z.-Z. |
| 臺大學術典藏 |
2019 |
MicroRNA in lung cancer metastasis
|
Wu S.-G.;Chang T.-H.;Liu Y.-N.;Jin-Yuan Shih; Wu S.-G.; Chang T.-H.; Liu Y.-N.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Yu C.-J.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; JIN-YUAN SHIH; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Jin-Yuan Shih;Yu C.-J.;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H. |
| 臺大學術典藏 |
2018-11-15 |
Miliary pulmonary nodules: An unusual presentation of leptospirosis
|
Yang, Ching Yao;Chen, Yung Hsuan;CHONG-JEN YU;JIN-YUAN SHIH; Chen, Yung Hsuan; Yang, Ching Yao; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation.
|
JIN-YUAN SHIH; Li-Ta Keng, Kuei-Pin Chung, Shu-Yung Lin, Sheng-Kai Liang, Jui-Chen Cheng, I-Chun Chen, Yen-Fu Chen, Hou-Tai Chang, Chia-Lin Hsu, Jih-Shuin Jerng, Hao-Chien Wang, Ping-Hung Kuo, Huey-Dong Wu, Jin-Yuan Shih, Chong-Jen Yu; PING-HUNG KUO; JIH-SHUIN JERNG; Chong-Jen Yu; HAO-CHIEN WANG; CHIA-LIN HSU; KUEI-PIN CHUNG; KENG LI-TA; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:03Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang, W.-C. and Xiao, F. and Shih, J.-Y. and Ho, C.-C. and Chen, Y.-F. and Tseng, H.-M. and Chen, K.-Y. and Liao, W.-Y. and Yu, C.-J. and Yang, J.C.-H. and Kuo, S.-H. and Cheng, J.C.-H. and Yang, P.-C. and Hsu, F.-M.; Chong-Jen Yu; WEI-YU LIAO; FU-REN XIAO; YA-FANG CHEN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:05:26Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
WEI-YU LIAO; Chong-Jen Yu; JIN-YUAN SHIH; Ho, C.-C. and Liao, W.-Y. and Lin, C.-A. and Shih, J.-Y. and Yu, C.-J. and Chih-Hsin Yang, J. |
| 臺大學術典藏 |
2018-09-10T18:04:14Z |
Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry
|
Gautschi, O. and Milia, J. and Filleron, T. and Wolf, J. and Carbone, D.P. and Owen, D. and Camidge, R. and Narayanan, V. and Doebele, R.C. and Besse, B. and Remon-Masip, J. and Janne, P.A. and Awad, M.M. and Peled, N. and Byoung, C.-C. and Karp, D.D. and Van Den Heuvel, M. and Wakelee, H.A. and Neal, J.W. and Mok, T.S.K. and Yang, J.C.H. and Ou, S.-H.I. and Pall, G. and Froesch, P. and Zalcman, G. and Gandara, D.R. and Riess, J.W. and Velcheti, V. and Zeidler, K. and Diebold, J. and Fr\\uh, M. and Michels, S. and Monnet, I. and Popat, S. and Rosell, R. and Karachaliou, N. and Rothschild, S.I. and Shih, J.-Y. and Warth, A. and Muley, T. and Cabillic, F. and Mazi\\`eres, J. and Drilon, A.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:13Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
|
Lin, Y.-T. and Liu, Y.-N. and Wu, S.-G. and Yang, J.C.-H. and Shih, J.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:13Z |
Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors
|
Wang, H.-Y. and Ho, C.-C. and Shih, J.-Y. and Ho, C.-C. and Shih, J.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:13Z |
Response to Stephane Renaud et al.
|
Yang, W.-C. and Shih, J.-Y. and Ho, C.-C. and Hsu, F.-M.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:10Z |
Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit
|
Chen, Y.-F. and Lin, J.-W. and Ho, C.-C. and Yang, C.-Y. and Chang, C.-H. and Huang, T.-M. and Chen, C.-Y. and Chen, K.-Y. and Shih, J.-Y. and Yu, C.-J.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:10Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yao, Z.-H. and Liao, W.-Y. and Ho, C.-C. and Chen, K.-Y. and Shih, J.-Y. and Chen, J.-S. and Lin, Z.-Z. and Lin, C.-C. and Yang, J.C.H. and Yu, C.-J.; Chong-Jen Yu; WEI-YU LIAO; JIN-YUAN SHIH; JIN-SHING CHEN |
| 臺大學術典藏 |
2018-09-10T18:04:09Z |
Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer
|
Chen, C.-Y. and Chen, Y.-Y. and Hsieh, M.-S. and Ho, C.-C. and Chen, K.-Y. and Shih, J.-Y. and Yu, C.-J.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:09Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:08Z |
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
|
Chen, C.-Y. and Chen, Y.-Y. and Chen, J.J.W. and Chen, K.-Y. and Ho, C.-C. and Shih, J.-Y. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:08Z |
Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma
|
Chang, L.-C. and Chen, K.-Y. and Shih, J.-Y. and Yu, C.-J. and Hsieh, M.-S.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:01:52Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang, T.-H. and Tsai, M.-F. and Gow, C.-H. and Wu, S.-G. and Liu, Y.-N. and Chang, Y.-L. and Yu, S.-L. and Tsai, H.-C. and Lin, S.-W. and Chen, Y.-W. and Kuo, P.-Y. and Yang, P.-C. and Shih, J.-Y.; YIH-LEONG CHANG; SUNG-LIANG YU; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:00:57Z |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population.
|
Chien-Hung Gow, Min-Shu Hsieh, Shang-Gin Wu, Jin-Yuan Shih; MIN-SHU HSIEH; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:00:51Z |
Comparable Clinical Outcomes in Patients with HER2-mutant and EGFR-mutant Lung Adenocarcinomas
|
Chien-Hung Gow and Hou-Tai Chang and Chor-Kuan Lim and Chao-Yu Liu and Jin-Shing Chen and Jin-Yuan Shih; JIN-YUAN SHIH; JIN-SHING CHEN |
| 臺大學術典藏 |
2018-09-10T15:38:24Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; 楊志新;蘇剛毅;廖唯昱;余忠仁;何肇基;阮聖元;施金元; Chen, Li-Yang; Chen, Li-Yang; Chong-Jen Yu; Molina-Vila, Miguel A.; WEI-YU LIAO; KAI-LUN YU; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Su, Kang-Yi; Su, Kang-Yi; CHAO-CHI HO; KANG-YI SU; Liao, Wei-Yu; Liao, Wei-Yu; Yu, Kai-Lun; Yu, Kai-Lun; JIN-YUAN SHIH; Yu, Kai-Lun; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Rosell, Rafael; Rosell, Rafael; Yang, Pan-Chyr; Yang, Pan-Chyr; Yang, Pan-Chyr; Chen, Li-Yang;Molina-Vila, Miguel A.;Ruan, Sheng-Yuan;Su, Kang-Yi;Liao, Wei-Yu;Yu, Kai-Lun;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin;Rosell, Rafael;Yang, Pan-Chyr; Chen, L.-Y. and Molina-Vila, M.A. and Ruan, S.-Y. and Su, K.-Y. and Liao, W.-Y. and Yu, K.-L. and Ho, C.-C. and Shih, J.-Y. and Yu, C.-J. and Yang, J.C.H. and Rosell, R. and Yang, P.-C. |
| 臺大學術典藏 |
2018-09-10T15:37:46Z |
Desquamative Interstitial Pneumonia Presenting with Consolidation and Hemoptysis
|
姚宗漢(Zong-Han Yao);郭順文(Shuenn-Wen Kuo);許嘉林(Chia-Lin Hsu);施金元(Jin-Yuan Shih);余忠仁(Chong-Jen Yu); JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:37:45Z |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu, Shang-Gin;Liu, Yi-Nan;Yu, Chong-Jen;Yang, Pan-Chyr;Shih, Jin-Yuan; Wu, S.-G. and Liu, Y.-N. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; 余忠仁;吳尚俊;施金元; Wu, Shang-Gin; Chong-Jen Yu; Wu, Shang-Gin; Liu, Yi-Nan; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Pan-Chyr; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T15:36:00Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao, B.-C. and Bai, Y.-Y. and Lee, J.-H. and Lin, C.-C. and Lin, S.-Y. and Lee, Y.-F. and Ho, C.-C. and Shih, J.-Y. and Chang, Y.-C. and Yu, C.-J. and Chih-Hsin Yang, J. and Yang, P.-C.; YEUN-CHUNG CHANG; Chong-Jen Yu; YEE-FAN LEE; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:34:47Z |
East Asian subgroup analysis of a randomized, double-blind, phase 3 study of docetaxel and ramucirumab versus docetaxel and placebo in the treatment of stage IV non-small cell lung cancer following disease progression after one prior platinum-based therapy (REVEL)
|
Park, K. and Kim, J.-H. and Cho, E.K. and Kang, J.-H. and Shih, J.-Y. and Zimmermann, A.H. and Lee, P. and Alexandris, E. and Puri, T. and Orlando, M.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:34:47Z |
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
|
Wu, J.-Y. and Shih, J.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:34:43Z |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
Wu, Shang-Gin;Chang, Yih-Leong;Yu, Chong-Jen;Yang, Pan-Chyr;Shih, Jin-Yuan; Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; 張逸良;楊泮池;余忠仁;吳尚俊;施金元; Wu, Shang-Gin; YIH-LEONG CHANG; Chong-Jen Yu; Chang, Yih-Leong; Yu, Chong-Jen; JIN-YUAN SHIH; Yang, Pan-Chyr; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T15:34:42Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
Shih, Jin-Yuan; Shih, Jin-Yuan; Yang, James Chih-Hsin; Lin, Yen-Ting;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Lin, Y.-T. and Yu, C.-J. and Yang, J.C.-H. and Shih, J.-Y.; 楊志新;余忠仁;林奕廷;林怡岑;施金元; 楊志新;余忠仁;林奕廷;林怡岑;施金元; Lin, Yen-Ting; Chong-Jen Yu; JIN-YUAN SHIH; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:34:42Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C. and Shih, J.-Y.; Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr;Shih, Jin-Yuan; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;施金元; Chen, Yen-Fu; MIN-SHU HSIEH; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; Chong-Jen Yu; Chang, Yih-Leong; JIN-YUAN SHIH; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T15:32:30Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin;Liu, Yi-Nan;Tsai, Meng-Feng;Chang, Yih-Leong;Yu, Chong-Jen;Yang, Pan-Chyr;Yang, James Chih-Hsin;Wen, Yueh-Feng;Shih, Jin-Yuan; Wu, S-G. and Liu, Y.-N. and Tsai, M.-F. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Yang, J.C.-H. and Wen, Y.-F. and Shih, J.-Y.; 楊志新;張逸良;楊泮池;余忠仁;溫岳峰;吳尚俊;施金元; YIH-LEONG CHANG; Tung, Li-Chen; Wu, Shang-Gin; Liu, Yi-Nan; Lin, Chin-Kai; Chong-Jen Yu; Hsieh, Ching-Lin; Tsai, Meng-Feng; JIN-YUAN SHIH; Chang, Yih-Leong; Chen, Ching-Chi; Huang, Chin-Tsan; Yu, Chong-Jen; Wang, Chun-Hou; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; ??M??; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:27:50Z |
Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer
|
Chen, C.-Y. and Lin, J.-W. and Huang, J.-W. and Chen, K.-Y. and Shih, J.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JENQ-WEN HUANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:27:22Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan
|
Hsu, Kuo-Hsuan;Ho, Chao-Chi;Hsia, Te-Chun;Tseng, Jeng-Sen;Su, Kang-Yi;Wu, Ming-Fang;Chiu, Kuo-Liang;Yang, Tsung-Ying;Chen, Kun-Chieh;Ooi, Hean;Wu, Tzu-Chin;Chen, Hung-Jen;Chen, Hsuan-Yu;Chang, Chi-Sheng;Hsu, Chung-Ping;Hsia, Jiun-Yi;Chuang, Cheng-Yen;Lin, Chin-Hung;Chen, Jeremy J. W.;Chen, Kuan-Yu;Liao, Wei-Yu;Shih, Jin-Yuan;Yu, Sung-Liang;Yu, Chong-Jen;Yang, Pan-Chyr;Chang, Gee-Chen; Hsu, K.-H. and Ho, C.-C. and Hsia, T.-C. and Tseng, J.-S. and Su, K.-Y. and Wu, M.-F. and Chiu, K.-L. and Yang, T.-Y. and Chen, K.-C. and Ooi, H. and Wu, T.-C. and Chen, H.-J. and Chen, H.-Y. and Chang, C.-S. and Hsu, C.-P. and Hsia, J.-Y. and Chuang, C.-Y. and Lin, C.-H. and Chen, J.J.W. and Chen, K.-Y. and Liao, W.-Y. and Shih, J.-Y. and Yu, S.-L. and Yu, C.-J. and Yang, P.-C. and Chang, G.-C.; 俞松良;蘇剛毅;楊泮池;廖唯昱;陳冠宇;余忠仁;何肇基;施金元; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chong-Jen Yu; Hsia, Te-Chun; WEI-YU LIAO; Tseng, Jeng-Sen; KANG-YI SU; JIN-YUAN SHIH; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T15:24:44Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Ho, Chao-Chi; Hsia, Te-Chun; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Tsung-Ying; Chang, Gee-Chen; Tseng, Chien-Hua; 楊泮池; SUNG-LIANG YU; WEI-YU LIAO; CHONG-JEN YU; KANG-YI SU; CHAO-CHI HO; JIN-YUAN SHIH; Yang, Pan-Chyret al. |
| 臺大學術典藏 |
2018-09-10T15:24:38Z |
Myxoma as a Rare Cause of Posterior Mediastinal Masses
|
王喬弘(Chiao-Hung Wang);鄭秀玲(Hsiu-Ling Cheng);蔡子修(Tzu-Hsiu Tsai);施金元(Jin-Yuan Shih); JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:24:38Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Hsu, Feng-Ming; Yousfi, Rahima; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Shih, Jin-Yuan; Shih, Jin-Yuan; Mohan, Viswaraman; Posch, Wilfried; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Wilflingseder, Doris; Lan, Keng-Hsueh; Lan, Keng-Hsueh; Moog, Christiane; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kodama, Eiichi N.; Kuo, Sung-Hsin; Clayette, Pascal; Lortat-Jacob, Hugues; Wu, Yuntao; 張淑媛; Chiang, Y. and Yang, J.C.-H. and Hsu, F.-M. and Chen, Y.-H. and Shih, J.-Y. and Lin, Z.-Z. and Lan, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Chiang, Yun;Yang, James Chih-Hsin;Hsu, Feng-Ming;Chen, Yu-Hsuan;Shih, Jin-Yuan;Lin, Zhong-Zhe;Lan, Keng-Hsueh;Cheng, Ann-Lii;Kuo, Sung-Hsin; 楊志新;郭頌鑫;鄭安理;陳育瑄;藍耿學;施金元;許峰銘; 楊志新;郭頌鑫;鄭安理;陳育瑄;藍耿學;施金元;許峰銘; JIN-YUAN SHIH; Connell, Bridgette Janine; Chiang, Yun; Yang, James Chih-Hsin; Chang, Sui-Yuan; Yang, James Chih-Hsin; ANN-LII CHENG; Prakash, Ekambaranellore |
| 臺大學術典藏 |
2018-09-10T15:24:38Z |
Hypereosinophilic Syndrome with Liver Involvement in Advanced Lung Cancer
|
胡釋文(Shih-Wen Hu);蔡子修(Tzu-Hsiu Tsai);施金元(Jin-Yuan Shih); JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:18:47Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
林家齊;楊志新;廖斌志;陳雅芳;余忠仁;何肇基;施金元;李日翔;張晉豪; Liao, Bin-Chi;Lee, Jih-Hsiang;Lin, Chia-Chi;Chen, Ya-Fang;Chang, Chin-Hao;Ho, Chao-Chi;Shih, Jin-Yuan;Yu, Chong-Jen;Yang, James Chih-Hsin; Chong-Jen Yu; Liao, Bin-Chi; Liao, Bin-Chi; YA-FANG CHEN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; CHAO-CHI HO; Lin, Chia-Chi; Lin, Chia-Chi; Chen, Ya-Fang; JIN-YUAN SHIH; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Shih, Jin-Yuan; Yu, Chong-Jen; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
顯示項目 231-280 / 468 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
